Acute Lymphoid Leukemia: Clinical Trials

2 trials for Acute Lymphoid Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Active not recruiting 1, Terminated 1

Follow Acute Lymphoid Leukemia: new trials by email Literature Review of Acute Lymphoid Leukemia trials Research Report on Acute Lymphoid Leukemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Orca-T, Standard-of-Care - Acute Myeloid Leukemia, Acute Lymphoid Leukemia
Phase 3Active not recruitingOrca Biosystems, Inc.1872022-06-212026-03-04
Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis
ARM A Cyclophosphamide, ARM B Calcineurin inhibitor and methotrexate - Acute Myelogenous Leukemia, Acute Lymphoid Leukemia
Phase 3TerminatedHospital Israelita Albert Einstein32012-12-012017-03-03

Narrower conditions

Leukemia, Myeloid, Acute (2)  ·  Myelodysplastic Syndromes (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Graft vs Host Disease (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Myeloproliferative Disorders (1)

Broader conditions

Bone Marrow Diseases (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Leukemia (2)  ·  Leukemia, Lymphoid (2)  ·  Leukemia, Myeloid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Myelodysplastic-Myeloproliferative Diseases (1)

Interventions

Calcineurin Inhibitors (1)  ·  Cyclophosphamide (1)  ·  Methotrexate (1)  ·  Standard of Care (1)

Sponsors

Hospital Israelita Albert Einstein (1)  ·  Orca Biosystems, Inc. (1)

Countries

Brazil (1)  ·  United States (1)

Top investigators

Paulo V Campregher, MD (1)

Results publications

PMID 41385341, PMID 42806776